We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDER™)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04181723
Recruitment Status : Completed
First Posted : November 29, 2019
Last Update Posted : February 17, 2022
Information provided by (Responsible Party):
ACADIA Pharmaceuticals Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 28, 2021
Actual Study Completion Date : October 28, 2021